GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sotac Pharmaceuticals Ltd (NSE:SOTAC) » Definitions » Other Income (Expense)

Sotac Pharmaceuticals (NSE:SOTAC) Other Income (Expense) : ₹8 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sotac Pharmaceuticals Other Income (Expense)?

Sotac Pharmaceuticals's other income expense for the Sotac Pharmaceuticals's pretax income for the three months ended in Sep. 2024 was ₹5 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₹8 Mil.

Sotac Pharmaceuticals Other Income (Expense) Historical Data

The historical data trend for Sotac Pharmaceuticals's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sotac Pharmaceuticals Other Income (Expense) Chart

Sotac Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Other Income (Expense)
0.75 0.02 - 6.77 1.47

Sotac Pharmaceuticals Quarterly Data
Mar20 Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.69 3.75 -2.89 2.48 4.52

Sotac Pharmaceuticals Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sotac Pharmaceuticals  (NSE:SOTAC) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Sotac Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sotac Pharmaceuticals Ltd (NSE:SOTAC) » Definitions » Other Income (Expense)
Comparable Companies
BOM:538964 BOM:540702 NSE:JFLLIFE BOM:524661 NSE:ZENITHDRUG BOM:540686 NSE:MADHAVBAUG BOM:524396 BOM:506919 BOM:524652 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
N/A
Address
Plot No. PF-21, Near ACME Pharma, Opposite Teva Pharma Sanand GIDC-II, Sanand, Ahmedabad, GJ, IND, 382110
Website
https://www.sotacpharma.com
Sotac Pharmaceuticals Ltd is a pharma manufacturer, specializing in the manufacturing of a wide range of pharmaceutical products such as Non-Beta-Lactam (general) tablets, beta-lactam coated tablets, beta-lactam uncoated tablets, Non-Beta-Lactam (general) capsules, beta-lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray, and cream.

Sotac Pharmaceuticals Headlines

No Headlines